Physician profile
David R Basch
NPI 1700863313
$906.76
in general payments reported to CMS, 2019-2025
13 companies · $54.56 in 2025
The $54.56 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $55.01 · 2021: $146 · 2022: $149 · 2023: $290 · 2024: $23.20 · 2025: $54.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenacare Global, LLC | $201.26 | 2023 | |
| Smith+Nephew, INC. | $161.11 | 2019-2021 | |
| Organogenesis INC. | $148.60 | 2020-2021 | |
| Stryker Corporation | $138.09 | 2020-2022 | |
| Treace Medical Concepts, INC. | $77.76 | 2024-2025 | |
| Vaporox, INC. | $42.23 | 2023 | Vht-200 Wound Treatment System |
| Bioventus LLC | $32.48 | 2019 | |
| Exact Sciences Corporation | $25.81 | 2023 | Cologuard Collection Kit |
| Acumed LLC | $20.21 | 2023 | Osteomed |
| Hartmann USA, INC. | $19.46 | 2022 | |
| Linvatec Corporation | $14.67 | 2022 | |
| Paragon 28, INC. | $14.18 | 2019 | |
| Arthrosurface Incorporated | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Basch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.